跳至主要内容
临床试验/IRCT201208041030N11
IRCT201208041030N11已完成2 期

Comparison of post-transplantation high dose cyclophosphamide versus Donor lymphocyte infusion (DLI) as relapse prophylaxis after haploidentical stem cell transplantation in high risk acute leukemia: A prospective randomized study

Hematology-Oncology & SCT Research Center0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 50 years(—)
性别
All

入选标准

  • Diagnosis of ALL or AML; Status of first complete remission (CR1) in high risk patients and second complete remission (CR2) for others; Age: 17-50; Karnofsky score 70-100; Life expectancy: 12 months; No Full matched donor (Related, Unrelated and Cord Blood); No candidate for autologous transplantation; Live enzyme < 2 upper normal limit (UNL) and Billirubin < 1.5 UNL; Cr < 1.4; Eject fraction (EF) > 45% and Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) greater than 45%; Human Immunodeficiency Virus (HIV) negative; No addiction. Exclusion criteria: Pregnancy; Breast feeding.

排除标准

  • 未提供

研究者

发起方
Hematology-Oncology & SCT Research Center

相似试验

招募中
2 期
Phase-II study on the value of post-transplant Cyclophosphamide after Thiotepa-based haplo-identical stem-cell transplantation for relapsed-refractory lymphomaC85.9Non-Hodgkin lymphoma, unspecified
DRKS00009880niversitätsklinikum Heidelberg49
进行中(未招募)
1 期
Phase-II study on the value of post-transplant Cyclophosphamide after Thiotepa-based haplo-identical stem-cell transplantation for relapsed-refractory lymphomaMyeloablative haplo-identical stem cell transplantation for poor risk non-hodgkin lymphoma
EUCTR2015-003920-30-DEniversity Hospital Heidelberg59
已完成
2 期
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell TransplantChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 PositiveDiffuse Large B-Cell LymphomaGraft Versus Host DiseaseMarginal Zone LymphomaMyeloproliferative NeoplasmRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Plasma Cell MyelomaRefractory Plasma Cell MyelomaSecondary Myelodysplastic SyndromeHodgkin LymphomaMyelodysplastic SyndromeMantle Cell LymphomaFollicular LymphomaAcute Leukemia
NCT03128359City of Hope Medical Center38
已完成
不适用
To study the effect of post-transplant cyclophosphamide pharmacology with transplant outcomes in patients undergoing haploidentical hematopoietic stem cell transplantatio
CTRI/2018/08/015152Department of Internal Medicine30
已完成
不适用
Comparison of intraoperative relatively high-dose and low-dose remifentanil for postoperative epidural analgesia after gynecological abdomonal surgerygynecological abdominal surgery
JPRN-UMIN000011185Department of anesthesiology, Faculty of medicine, University of Tsukuba30